An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

NCT00760669 · clinicaltrials.gov ↗

COMPLETED

Status

1061

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing
Arthritis, Rheumatoid
Psoriasis
Arthritis, Psoriatic

Interventions

DRUG: Infliximab; observational study
DRUG: Methotrexate; observational study

Sponsor

Janssen Korea, Ltd., Korea